Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?

被引:5
作者
Krajewski, Piotr K. [1 ,2 ]
Marron, Servando E. [2 ,3 ]
Aragones, Lucia Tomas [3 ,4 ]
Gilaberte-Calzada, Yolanda [2 ]
Szepietowski, Jacek C. [1 ]
机构
[1] Wroclaw Med Univ, Dept Dermatol Venereol & Allergol, Chalubinskiego St 1, PL-50368 Wroclaw, Poland
[2] Univ Hosp Miguel Servet, Dermatol Dept, Paseo Isabel la Catolica 1-3, Zaragoza 50009, Spain
[3] Aragon Psychodermatol Res Grp GAI PD, Calle San Juan Bosco 13, Zaragoza 50009, Spain
[4] Univ Zaragoza, Dept Psychol, Calle Pedro Cerbuna 12, Zaragoza 50009, Spain
关键词
Hidradenitis suppurativa; Self-reported severity; Hurley; Assessment; QUALITY INDEX DLQI; PSYCHOLOGICAL BURDEN; DERMATOLOGY; VALIDATION; LIFE; PSORIASIS; OUTCOMES; AREA; TOOL;
D O I
10.1007/s13555-022-00701-5
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Introduction Hidradenitis suppurativa (HS) is considered to be the most burdensome dermatosis, with a well-documented negative influence on quality of life (QoL). The patient's perception of the disorder, assessed as the self-reported severity, has been used in other dermatoses but not in HS. The aim of this study was to evaluate the usefulness of self-reported HS severity in clinical practice. Methods The study was performed on a group of 130 Spanish HS patients. HS severity was assessed for all the subjects. Hurley staging and patient self-reported severity were used. Moreover, QoL impairment was evaluated using the Dermatology Life Quality Index (DLQI) and the Hidradenitis Suppurativa Quality of Life 24 (HSQoL-24) questionnaire. Results The severity of HS according to the Hurley staging was most commonly assessed as Hurley II (47.7%), indicating moderate disease, followed by severe disease (Hurley III, 26.9%) and mild disease (Hurley I, 25.4%). According to the patient self-reported HS severity, most of the patients reported having mild disease (76 patients, 58.5%), followed by moderate disease (31 patients, 23.8%). Only 23 patients (17.7%) assessed their disease as severe. Moreover, men reported mild disease significantly more frequently than women (70.9% and 49.3%, respectively; p = 0.014). The self-reported HS severity correlated positively with the effect of the disease on patient QoL assessed with DLQI (r = 0.288, p < 0.001). Likewise, a strong positive correlation was found between self-reported HS severity and QoL impairment assessed with HSQoL-24 (r = 0.404, p = 0.001). No statistically significant correlation between Hurley severity stage and DLQI or HSQoL-24 was found. Moreover, there were significant differences in both DLQI and HSQoL-24 total score between different self-reported HS severities. This was not seen for any of the QoL instruments or for Hurley severity staging. Conclusion The results show that self-assessment severity may reflect patients' subjective feelings more adequately than popular objective instruments, and there should be a place for its use in daily clinical practice.
引用
收藏
页码:899 / 909
页数:11
相关论文
共 35 条
[1]   Patient-reported outcome measures and qualitative research in dermatology: the quest for authenticity [J].
Apfelbacher, C. J. ;
Nelson, P. A. .
BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (02) :285-287
[2]  
Basch Ethan, 2018, Am Soc Clin Oncol Educ Book, V38, P122, DOI 10.1200/EDBK_200383
[3]   The patient-oriented eczema measure - Development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective [J].
Charman, CR ;
Venn, AJ ;
Williams, HC .
ARCHIVES OF DERMATOLOGY, 2004, 140 (12) :1513-1519
[4]   Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa [J].
Chernyshov, P. V. ;
Zouboulis, C. C. ;
Tomas-Aragones, L. ;
Jemec, G. B. ;
Svensson, A. ;
Manolache, L. ;
Tzellos, T. ;
Sampogna, F. ;
Pustisek, N. ;
van der Zee, H. H. ;
Marron, S. E. ;
Spillekom-van Koulil, S. ;
Bewley, A. ;
Linder, D. ;
Abeni, D. ;
Szepietowski, J. C. ;
Augustin, M. ;
Finlay, A. Y. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (09) :1633-1643
[5]   Quality of Life in Hidradenitis Suppurativa: An Update [J].
Chernyshov, Pavel, V ;
Finlay, Andrew Y. ;
Tomas-Aragones, Lucia ;
Poot, Francoise ;
Sampogna, Francesca ;
Marron, Servando E. ;
Zemskov, Sergey, V ;
Abeni, Damiano ;
Tzellos, Thrasyvoulos ;
Szepietowski, Jacek C. ;
Zouboulis, Christos C. .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (11)
[6]   The Simplified Psoriasis Index (SPI): A Practical Tool for Assessing Psoriasis [J].
Chularojanamontri, Leena ;
Griffiths, Christopher E. M. ;
Chalmers, Robert J. G. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 (08) :1956-1962
[7]   Impact of Measuring Patient-Reported Outcomes in Dermatology Drug Development [J].
Copley-Merriman, Catherine ;
Zelt, Susan ;
Clark, Marci ;
Gnanasakthy, Ari .
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2017, 10 (02) :203-213
[8]   Etanercept: effective in the management of hidradenitis suppurativa [J].
Cusack, C ;
Buckley, C .
BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (04) :726-729
[9]   The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries [J].
Dalgard, Florence J. ;
Gieler, Uwe ;
Tomas-Aragones, Lucia ;
Lien, Lars ;
Poot, Francoise ;
Jemec, Gregor B. E. ;
Misery, Laurent ;
Szabo, Csanad ;
Linder, Dennis ;
Sampogna, Francesca ;
Evers, Andrea W. M. ;
Halvorsen, Jon Anders ;
Balieva, Flora ;
Szepietowski, Jacek ;
Romanov, Dmitry ;
Marron, Servando E. ;
Altunay, Ilknur K. ;
Finlay, Andrew Y. ;
Salek, Sam S. ;
Kupfer, Joerg .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (04) :984-991
[10]   Hidradenitis suppurativa: a pilot study to determine the capability of patients to self-assess their Hurley stage [J].
Deckers, I. E. ;
Mihajlovic, D. ;
Prens, E. P. ;
Boer, J. .
BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (05) :1418-1419